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Abstract 
 
Purpose: 
To demonstrate how the information extracted from scientific text can be directly used in 
support of life science research projects. In modern digital-based research and academic 
libraries, librarians should be able to support data discovery and organization of digital 
entities in order to foster research projects effectively; thus we speculate that text mining and 
knowledge discovery tools could be of great assistance to librarians. Such tools simply 
enable librarians to overcome increasing complexity in the number as well as contents of 
scientific literature, especially in the emerging interdisciplinary fields of science. In this paper 
we present an example of how evidences extracted from scientific literature can be directly 
integrated into in silico disease models in support of drug discovery projects. 
 
Design/methodology/approach: 
The application of text-mining as well as knowledge discovery tools are explained in the form 
of a knowledge-based workflow for drug target candidate identification. Moreover, we 
propose an in silico experimentation framework for the enhancement of efficiency and 
productivity in the early steps of the drug discovery workflow. 
 
Findings: 
Our in silico experimentation workflow has been successfully applied to searching for hit and 
lead compounds in the World-wide In Silico Docking On Malaria (WISDOM) project and to 
finding novel inhibitor candidates.  
 
Practical implications: 
Direct extraction of biological information from text will ease the task of librarians in 
managing digital objects and supporting research projects. We expect that textual data will 
play an increasingly important role in evidence-based approaches taken by biomedical and 
translational researchers. 
 
Originality / value: 
Our proposed approach provides a practical example for the direct integration of text- and 
knowledge-based data into life science research projects, with the emphasis on its 
application by academic and research libraries in support of scientific projects. 
 
Paper type: 
Conceptual paper 
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1. Introduction 
The Life Sciences (biology, biochemistry, medicine) are still dominated by empirical 
observations. Because of this empirical nature of the life sciences there is a flood of 
descriptive publications in this domain. Besides a remarkable increase in the complexity of 
the scientific content of life science publications (e.g. observations that cross the borders of 
traditional disciplines, indicated by new journals with names such as NATURE Chemical 
Biology), the number of journals is also growing fast. Approximately 13,000 biomedical 
journals are being published currently throughout the world, among which more than 5000 
are currently indexed for MEDLINE in the fields of biomedicine and life sciences 
(www.nlm.hin.gov/pubs/factsheets). Moreover, about 120 new journals are added to 
MEDLINE every year (Kotzin, 2005). This increasing volume of information poses a great 
challenge to life scientists to search, retrieve and extract relevant data in an efficient and 
reliable manner. In response to this challenge, automated methods for information retrieval 
and information extraction (“text mining”) have been developed and continuously improved. 
These technologies have recently reached a degree of maturity that enhances the 
searchability of traditional information retrieval systems through different techniques such as 
query refinement, semantic searching, document clustering and categorization, and 
summarization (Mack and Hehenberg, 2002). However, the indispensable part of information 
retrieval (IR) systems is information extraction (IE), which is intended to identify and extract 
specific biological terms (named entity recognition, NER) and their relationships 
automatically. IE techniques are evolving at a faster pace recently, making use of the rapid 
development of semantic annotations and ontologies, which help to classify mentions of text 
entities and enable true semantic search by mapping named entities to classes of entities 
(e.g. the named entity “Alzheimer” belongs to the class “diseases”). Unstructured information 
sources such as scientific text are rich in useful information on e.g. diseases and their 
molecular etiology. Such information is often represented in text by associations among 
similar or different biological entities (i.e. genes, proteins, drugs, allelic variants, etc). In 
addition to their capability to retrieve and extract “direct relationships” among biological 
entities (e.g. published facts), text-mining techniques can be leveraged to detect ‘invisible’ 
patterns or ‘indirect’ associations among different entity types. For example, if protein A 
interacts with protein B and protein B interacts with protein C, it can be inferred that protein A 
might also interact with protein C in a complex. Therefore, text mining can be used to 
enhance data mining capabilities. As such, it would be interesting to mine indirect 
associations, for example, between drug-drug, drug-pathway, drug-marker, and drug-clinical 
outcome information. In this paper, we explain how the information extracted from scientific 
text can be directly incorporated into the process of modeling pathogenesis and simulation of 
in silico experiments using computational tools and high-performance computing 
infrastructures. 
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2. Technologies used for information extraction from text and images 
Technologies for Information extraction (IE) which are currently widely used are based on 
two approaches: natural language processing (NLP) and statistical methods, namely co-
occurrence of entities (Jensen et al., 2006). Using NLP methods, biomedical information 
within free text is mined through part-of-speech (POS) taggers or part-of-speech stemmers. 
While the first method labels each word in the sentence according to its grammatical 
position, the second one recognizes the morphological root of the word (stemming).  
Since information extraction deals with the semantic structure of the text, the first step toward 
IE is to identify and tag biological entities in the text; this process, which is called “named 
entity recognition” (NER), is an active area of research due to the increasing complexity of 
biomedical language and vocabulary (Krallinger et al., 2005). Rule-based methods, 
dictionary-based approaches or a combination of these two techniques are often used for 
information extraction from the text. Table 1 lists different methods which are currently used 
for IE purposes in the life sciences domain.  
 
Table 1. List of different methods that are applied to Information Extraction 
IE methods Approach 
Rule-based pattern extraction  Learned regular expression 
patterns 
Sequence tagging by machine 
learning 
Probabilistic sequence models 
(HMM*, CRF**), induced 
classifiers 
Dictionary-based pattern 
matching 
Named entity recognition 
       * Hidden Markov Models (Rabiner, 1989) 
** Conditional Random Fields (Lafferty et al., 2001) 
 
A prerequisite for IE is entity recognition which is considered one of the most challenging 
areas in text mining, mainly due to the lack of standard naming (Jensen et al., 2006).  
Abbreviations and synonyms, which represent biological named entities in the text should be 
distinguished from the background; for instance, the gene name “AR” which stands for 
androgen receptor should be distinguished from the acronym for “Arkansas state”.   
Therefore, recent systems are supported by ontologies or dictionaries containing a 
comprehensive list of synonyms in order to reduce the number of false positives; for 
example, ProMiner developed at Fraunhofer Institute for Algorithms and Scientific 
Computing, SCAI, (Hanisch et al., 2005) is a rule-based system that is supported by regularly 
updated organism-specific dictionaries. The system resolves the ambiguities using context 
information and is aware of acronyms (Figure 1).  
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Figure 1. Visualization of ProMiner performance on recognition of biological named entities. 
In this example, the word “CAT” has been correctly detected as gene name for Catalase; 
genes/proteins, drugs, and disease are also highlighted by gray 
 
As well as free text, images constitute another source of relevant information, which is 
frequently found in publications, especially in the chemical and biochemical domain. The 
above-mentioned text mining technologies have contributed significantly to the progress of 
recognition and extraction of chemical named entities from text and image captions, but the 
big challenge with chemical structure depictions is how to convert a structural image to a 
computer readable structure representation format; such structural data can be stored in 
searchable databases and used for drug discovery purposes (Banville, 2006).  The first 
attempts at automated extraction of chemical structure information from images and their 
conversion into computer readable chemical structure representation formats appeared in 
the 1990s (McDaniel and Balmuth, 1992). A commercial tool for extraction of chemical data 
from literature, CLiDE, (standing for “chemical literature data extraction”) was developed in 
the middle of the 1990s (Ibison et al., 1993). Very recently, an advanced tool for chemical 
structure mining (chemoCRTM) has been developed at Fraunhofer Institute SCAI. chemoCR 
combines pattern recognition techniques with supervised machine-learning concepts and a 
chemical expert system in order to identify the most significant semantic entities (e.g. chiral 
bonds, super atoms, reaction arrows, etc.) from chemical depictions. The system is still being 
improved, but the current version is now “production ready”, meaning that chemical 
structures can be directly used as input into in silico experimentation such as virtual 
screening.  
 
 
 
 5
3. Direct application of extracted data from text to in silico experiments 
Given such considerable advancements in information extraction from text and images, one 
might ask how these data extracted from the literature can be used to enhance our 
understanding and knowledge in the biomedical domain. In their review, Krallinger et al. 
(2005) point out four applications for text mining, namely functional annotation of genes and 
proteins, extraction of subcellular localizations, statistical analysis of gene expression 
articles, and prediction of protein-protein interactions. Among these applications, the 
statistical approaches have been extended to annotating the content of expression 
databases; for example, very recently Ruau et al. (2008) used ProMiner (Hanisch et al., 
2005) to annotate data entries (biological sample information) in the Gene Expression 
Omnibus (GEO) microarray repository by employing text-mining and expression profile 
correlation. In this way, the annotation process could be automated.  
In addition to the usage scenarios mentioned by Krallinger et al. (2005), we foresee that 
extracted data from scientific publications can be directly used in in silico experiments. An in 
silico experiment has been defined as “a procedure that uses computer-based information 
repositories and computational analysis to test a hypothesis, derive a summary, search for 
patterns, or demonstrate a known fact” (Foster and Kesselman, 1999). In other words, an in 
silico experiment involves the use of local and remote resources to test a hypothesis 
(Stevens et al., 2003). Since biological systems comprise of dynamic interactions between 
non-linear processes on tempo-spatial scales, their analysis and modeling requires 
integration of all relevant information at multiple levels from molecular and cellular to organ 
levels. For this reason, life scientists frequently need to collect information from different 
databases such as EntrezGene, SwissProt, or PDB (Protein Data Bank), and use them in 
combination in order to be able to test their hypotheses in the in silico environment before 
they proceed to the more expensive and time-consuming experimental lab work. Therefore, 
computer models and simulation environments provide the researchers with a convenient 
test ground to go through the process of “trial and error” and further optimize and validate the 
outcome of their experiments before proceeding to the real experimental settings in the 
molecular biology laboratory. In the following, we demonstrate how literature-based 
information is directly used in in silico modeling and simulation experiments. 
 
 
3.1 In silico Network-based modeling of complex diseases 
Many human diseases (over 1500) have been found to result from a defect in the function of 
a single gene; for example sickle-cell anaemia is a blood disorder which is characterized by 
abnormal sickle shape of red blood cells because of a mutation in the haemoglobin gene. 
Such so-called “Mendelian” diseases occur rarely and their transmission follows a 
characteristic pattern (e.g. dominant, recessive, sex-linked). However, there are many other 
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diseases that are more “common” in the human population and their inheritance follows a 
familial pattern; such diseases are often referred to as “complex diseases” because they are 
not the result of simple Mendelian inheritance (Botstein and Risch, 2003); instead they are 
likely to arise from mutations in more than one gene or different mutations in the same gene 
(Goh et al., 2007). Usually an unknown number of multiple defected genes are involved, 
which are also interacting with environmental factors and lead to the manifestation of such 
diseases as coronary heart disease, hypertension, diabetes, obesity, various cancers, and 
neurodegenerative diseases (Motulsky, 2006). 
The polygenic nature of complex diseases (contribution of many mutated genes with low 
effect) has a great impact on the underlying cellular network at different molecular levels from 
gene expression to proteomic and metabolic levels. In other words, for us to be able to 
understand the biological mechanism(s) underlying complex diseases, it is necessary to 
consider the contribution of all possible defected genes and their products in a network of 
dependencies. Nowadays, high-throughput technologies have made it possible to look at the 
disease state from a global or system view and have produced a large amount of data at 
each molecular level. For instance, genome chip and microarray technology now allows us to 
study the activity of large numbers of genes simultaneously and to create a global picture of 
cellular function under different conditions (disease vs. healthy samples).  
Integration of all such data into comprehensible models using computational tools allows us 
to understand the biological complexity behind complex diseases by simulating the behaviour 
of cells under disease conditions in a virtual environment. In silico modeling provides a 
suitable framework for the integration of high-dimensional data across different biological 
domains which can be used for hypothesis generation and prediction; for example, in a 
cellular interaction network proper intervention points can be hypothesized as drug target 
candidates and modulating these points in silico may predict the clinical readout at the 
phenotypic level (Butcher et al., 2004). Recent application of network theory to the biological 
field has laid down the foundation of a model framework known as “integrative functional 
informatics” or “integrative bioinformatics” (Figure 2). 
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Figure 2. A systems biology view at the pathogenesis mechanisms in cancer. The aim of 
integrative bioinformatics is to aggregate the biological data at different levels and derive a 
model that is an indicator of underlying cellular interactions under disease state. 
 
Network-based models have been successfully constructed and employed to tackle the 
complexity of common diseases from different angles, including identification of disease-
modifying proteins in ataxia (Lim et al., 2006), finding novel drug targets for prostate 
adenocarcinoma (Ergun et al., 2007), analysis of allergic response in asthma (Lu et al., 
2007), and network-based classification of breast cancer metastasis (Chuang et al., 2007). 
Such networks represent the reduced form of complex interactions among cellular 
components so that each node stands for a molecular component and two nodes are 
connected with a link if they interact. The nodes and links together form an interaction 
network, which is translated into the mathematical language of graphs (Barabasi and Oltvai, 
2004). Networks serve as models for the integration of cellular information as well as the 
generation of a predictive hypothesis about the behavior of a biological system; for example, 
if changes in gene activity can be mapped to changes of corresponding secreted proteins in 
the blood, perhaps diagnosis of the disease could be easily done by testing the amount of 
such proteins in the blood (Hood et al., 2004). 
Evidence extraction from literature is often the preliminary step in formulating a network 
hypothesis for disease modeling. For instance, Pujana et al. (2007) first constructed a 
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literature-based network of human Protein-Protein Interaction (PPI) using four reference 
genes and then projected gene co-expression profiles onto this network; they enriched the 
resultant networks with additional information from human and other model organisms and 
successfully identified and experimentally validated a new component of this susceptibility 
network. 
Each individual has a unique genetic makeup and this uniqueness accounts for the 
phenotypic variations observed among individuals in the human population (Kruglyak and 
Nickerson, 2001). These variations in genetic composition (also called “genetic 
polymorphisms”) may have a great impact on disease susceptibility. Such polymorphisms 
constitute the genetic component of complex human diseases but they are thought to trigger 
the process of pathogenesis under the influence of environmental factors. To find out which 
genetic variants increase disease risk, all the variations across the human genome are 
genotyped and those variants which are quantitatively recognized as risk factors are 
determined. Identification of susceptibility genes is a progressing field of research, as it is 
expected that many susceptibility variants will be discovered in the future (Iles, 2008). 
In an attempt to identify the most important susceptibility players in breast cancer and to 
explore their relationships with other known susceptibility mutations in humans, our group at 
Fraunhofer SCAI used a network-based approach to test the hypothesis that single-point 
errors in the genetic code of multiple proteins lead to an increased level of susceptibility to 
breast cancer and that the degree of susceptibility depends on the position and function of 
each protein in the entangled network of cellular interactions. For this purpose, a human PPI 
network, relevant to breast cancer, was constructed and the susceptibility dataset drawn 
from 1140 patients with breast cancer (Hunter et al., 2007) was mapped onto this network. 
This network was topologically characterized and also compared to the randomized version. 
Topological and functional analyses of this network identified 13 significant genes which 
might play a central role in conferring susceptibility to the development of breast tumors. In 
parallel, we employed SCAIview – a knowledge discovery tool developed at Fraunhofer SCAI 
(Friedrich et al., 2008) - to reconstruct a literature-based network of gene co-citations 
relevant to breast cancer. To explore novel susceptibility associations between our 13 genes 
and other known ones, we overlaid the co-citation network on the PPI network and found 
overall 23 novel associations from which 7 associations could be directly or indirectly 
validated by the literature. Our findings are consistent with the fact that many susceptibility 
genes have not yet been discovered due to the low heritability of complex traits as well as 
the underpowered statistical methods used in linkage analyses (Hirschhorn and Daly, 2005). 
This example shows that the information embedded in free text can be used for more 
sophisticated purposes than simply extraction of biological entities. Enrichment of molecular 
 9
network analyses with text-mining data not only increases the added value of the analysis, 
but also strengthens the validity and interpretability of the results. 
 
3.2 In silico experimental environment for high-throughput screening 
With the advent of high-throughput technologies, researchers are now confronted with 
massive amounts of biological data, which have to be analyzed and interpreted with the help 
of bioinformatics applications. By integrating different biological datasets, life scientists are 
able to study the biological system as a whole and thus systems biology approaches are 
becoming more popular in the course of routine research activities. However, pattern 
detection, modeling and simulation of the biological system, and hypothesis testing are 
prerequisite steps in the cycle of systems biology approaches (Figure 3). This strategy has 
already been adopted by the pharma industry and academia for drug discovery purposes. 
One limiting factor in adopting this strategy is the demand for high-performance 
computational capacities. Hence, the concept of the “virtual laboratory” has been introduced, 
in which computational distributed resources are used as an electronic workspace for drug 
target identification, selection, and validation (Rauwerda et al., 2006). Grid technology 
provides a computational backbone for this purpose (Konagaya, 2006).  
 
 
Figure 3. The cycle of systems biology approaches to disease modeling and prediction. 
 
 
High-throughput virtual screening by molecular docking is an example of an in silico 
experiment which replaces the high-cost procedure of real HTS (High-Throughput Screening) 
in experimental laboratories and makes it possible to perform screening of millions of 
compounds on interesting target proteins in a relia
 10
et al., 2006). This approach has been successfully applied to searching for hit and lead 
compounds in the World-wide In Silico Docking On Malaria (WISDOM) project (Jacq et al., 
2008).  
The WISDOM project encompasses a collaborative framework, which has been established 
between bioinformaticians, biochemists, pharmaceutical chemists, biologists and grid 
computing experts in order to produce and make selected lists of potential inhibitors 
available. WISDOM-I, the first large scale deployment of the molecular docking application 
on EGEE (Enabling Grids for E-sciencE) [i], which took place from August 2005 to 
September 2005, has seen 42 million dockings, which is equivalent to 80 years of CPU time. 
Virtual screening of 500,000 chemical compounds was performed using FlexX software 
against different plasmepsins (aspartic protease implicated in haemoglobin degradation). On 
the biological front, three scaffolds were identified, one of which is the guanidino scaffold, 
which is likely to be novel as they have not been reported as plasmepsin inhibitors before. 
Experimental results proved that the compounds selected from WISDOM-I function as sub-
micromolar inhibitors against plasmepsin (Kasam et al., 2007; Jacq et al., 2008). The 
complete workflow employed in the WISDOM project is shown in Figure 4. 
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Figure 4. Description of the in silico experimentation workflow deployed in the WISDOM 
project for large scale screening of compounds against Malaria.  
 
With the success achieved by the WISDOM-I project on both the computational and 
biological sides, several scientific groups around the world proposed targets implicated in 
malaria, which led to the second assault on malaria, WISDOM-II (Kasam et al., 2007). 
The target portfolio was broadened, and the ZINC database (4.3 million chemical 
compounds) was screened against four different targets implicated in malaria. Over the 
course of 90 days during the winter of 2006, 140 million dockings were recorded, which is 
equivalent to 413 years of CPU time, representing an average throughput of almost 80,000 
dockings per hour. This was made possible by the availability of thousands of CPUs through 
different infrastructures worldwide. Experimental testing of the compounds finally selected 
against all the targets is ongoing. 
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4. Linking disease modeling to grid-based target identification 
Normally a research process starts with an exploration of a scientific domain by collecting 
relevant data, information, and previous knowledge, which are often hidden in scientific 
publications. Accordingly, referring to the scientific literature is usually the first step towards 
selection of drug targets and validation processes (Whittaker, 2004) because it provides a 
valid and proper framework for drug target identification purposes. When merged with 
network-based disease models, the information extracted from the text enhances confidence 
about the drugability of the candidate target. Moreover, it would be possible to generate 
informative profiles for each candidate target using information extracted from the text; i.e. 
literature-based annotation of target nodes on the network model of disease provides 
enormous insight about drug candidate efficacy and toxicity. Such profiles will be of high 
value for ranking or prioritizing target candidates. Another potential application field for this 
strategy is the emerging phenomenon of Polypharmacology in which the drugability of a 
specific ligand against multiple targets (rather than a single target) is assessed for treatment 
of polygenic complex diseases (Hopkins, 2008).  
To this end, we have devised a knowledge-based workflow for target candidate identification, 
which incorporates the information extracted from the text directly into the network-based 
disease model (Figure 5). In this workflow, information retrieval is performed on PubMed 
abstracts using the user’s search query in a context-sensitive manner. Information extraction 
is accomplished on a relevant subcorpus by a rule-based system that employs a machine-
learning technique and resolves the ambiguity problem by using regularly updated organism-
specific dictionaries (Hanisch et al., 2005). The system returns the results according to 
statistical ranking of entities found, based on Kullback-Leibler divergence (relative entropy), 
meaning that the more relevant entities (e.g. gene names) appear in the top of the ranking 
list. This system is able to extract co-mentioned biological entities (e.g. gene-gene, protein-
protein) and export them as a co-occurrence network together with the corresponding 
frequencies of co-mentions in the literature. These frequencies can be later used as the 
weight of edges in the co-occurrence network for filtering purposes. This co-occurrence 
network passes through the next module which compiles a protein-protein interaction (PPI) 
network from manually curated databases such as DIP (Datase of Interacting Proteins), 
BIND (Biomolecular Interaction Network Database), HPRD (Human Protein Reference 
Database), etc. Since the PPI network is constructed using expert-curated protein interaction 
data from databases, it provides a well-defined backbone for mapping the co-occurrence 
network and exploring potential novel associations suggested by the text mining approach. 
The output of the workflow is a network model which consists of both curated and text-based 
information and can be further enriched by different types of biological data adopted from 
molecular databases (e.g. gene expression values) or from the text itself (e.g. pathological or 
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clinical context). This network model is then subjected to statistical analysis to identify the 
key biological elements correlated with the pathogenesis mechanism. 
 
 
Figure 5. A knowledge-based workflow for target candidate identification. The information 
from the text is incorporated in the form of co-occurrences and annotations which are directly 
extracted by  the SCAIView knowledge discovery tool. 
 
 
The advantage of the text-mining data over expert curated data is that text-mining data are 
extracted from up-to-date information in the literature, thus increasing the chances of 
uncovering novel associations.  Whereas manually (expert) curated data represent well-
established knowledge (which is often represented in cartoon-like schemata), text-mining 
derived knowledge seems to be more suited to fostering the generation of novel hypotheses. 
The results from the above workflow are hypothetical suggestions and need to be tested in 
an in silico environment using simulation techniques; by this means, it can be ensured that 
the most promising target candidate will be selected to pass through the next expensive 
steps of the drug discovery pipeline. Automatic ligand-target dockings on high-performance 
grid computing infrastructures can help us effectively for this purpose: a library of numerous 
drug-like molecules is docked against candidate targets and consequently docking properties 
for all ligand-target combinations can be computed on a grid-enabled high-performance 
architecture in a very time- and computational-efficient manner. The most promising 
combinations are then selected and directed towards the next steps of the drug discovery 
pipeline (Figure 6). 
 14
 
Figure 6. Proposed in silico experimentation framework for the enhancement of efficiency 
and productivity in the early steps of the drug discovery workflow. 
 
In conclusion, the embedding of text and data mining methodologies in the architecture of in 
silico experimentation environments not only complements the experimental data but also 
enhances the predictive power of the resultant semantic model for the disease in question. 
Currently, drug development and productivity is facing a high rate of failure (as much as 
30%) due to a lack of efficacy and clinical safety (Kola and Landis, 2004). Integration of 
literature evidence into in silico disease models at the very beginning of the drug discovery 
pipeline, as well as providing a high-performance simulation infrastructure for in silico testing 
of drug target candidates, generated from the hypothetical results of in silico disease models, 
will be of high value for overcoming such attritions.  
 
 
5. Looking to the future 
Direct extraction of biological information from text will certainly ease the curation process for 
databases, which is a challenging task for database annotators and domain experts. But it 
can be foreseen that in the not so distant future, textual data will be an indispensable part of 
“integrative biology” models, which aim at predicting biological outcomes by putting different 
components together.  
The information encoded in the body of scientific literature has more to offer than can be 
found by traditional reading of publications one by one. The ability to look at hundreds of 
thousands of publications simultaneously and to do statistical analysis on factual statements 
in scientific text opens new perspectives for scientific work in the life sciences. For example, 
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another type of data that is of enormous potential in biomarker and target discovery 
corresponds to clinical outcome information, which reflects the physiological response to a 
drug or the diagnostic/prognostic value of specific biomarkers. So far such information in the 
text has been underutilized, although they offer complex descriptions of disease genotype 
and phenotype. Hence, there is a need to develop specialized terminologies for the 
extraction of clinical and biomarker information from the literature. Moreover, we expect that 
textual data embedded in the biomedical literature will play an important role in evidence-
based approaches in medicine, such as empowering clinical decision-support systems by 
means of automated screening of scientific text for statements encoding medical evidence. 
 
Notes 
[i] http://www.eu-egee.org/ 
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